Document Detail


Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism.
MedLine Citation:
PMID:  11298731     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It is well known that thyroid hormones modulate lipoprotein metabolism. Thus, the presence of clinical or subclinical hyperthyroidism may influence lipid parameters of dyslipidaemic patients and the efficacy of hypolipidaemic therapy. Here we present a patient with mixed hyperlipidaemia whose impressive improvement of his lipid profile following ciprofibrate administration pointed towards the diagnosis of asymptomatic underlying subclinical hyperthyroidism.
Authors:
E Liberopoulos; G Miltiadous; M Elisaf
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Diabetes, obesity & metabolism     Volume:  3     ISSN:  1462-8902     ISO Abbreviation:  Diabetes Obes Metab     Publication Date:  2001 Apr 
Date Detail:
Created Date:  2001-04-12     Completed Date:  2001-06-07     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  100883645     Medline TA:  Diabetes Obes Metab     Country:  England    
Other Details:
Languages:  eng     Pagination:  97-8     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antilipemic Agents / therapeutic use*
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Clofibric Acid / analogs & derivatives,  therapeutic use
Humans
Hyperlipidemias / complications,  drug therapy*
Hyperthyroidism / complications,  diagnosis*
Lipids / blood*
Male
Middle Aged
Thyrotropin / blood
Thyrotropin-Releasing Hormone / diagnostic use
Thyroxine / blood
Triglycerides / blood
Triiodothyronine / blood
Chemical
Reg. No./Substance:
0/Antilipemic Agents; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Lipids; 0/Triglycerides; 24305-27-9/Thyrotropin-Releasing Hormone; 52214-84-3/ciprofibrate; 6893-02-3/Triiodothyronine; 7488-70-2/Thyroxine; 882-09-7/Clofibric Acid; 9002-71-5/Thyrotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Early insulin release effectively improves glucose tolerance: studies in two rodent models of type 2...
Next Document:  Effects of the Magenstrasse and Mill operation for obesity on plasma leptin and insulin resistance.